Xcellerex

xcellerex is revolutionizing the way biomolecules are developed, manufactured and commercialized. xcellerex is built around a unique biomanufacturing platform that features the innovative application of single-use component technology. the xcellerex platform transforms biomanufacturing economics by enabling: > faster deployment of new manufacturing capacity: 12-18 months vs. 3-5 years. > reduced capital investment: typical savings of 50% to 70% compared to conventional approaches. > unmatched flexibility: modular microenvironment approach enables fast, low-cost redeployment for multi-drug production. xcellerex offers a suite of world-class products and services to support the adoption of its platform. these include the xdr line of single-use bioreactors, pdmax® high-throughput process development and optimization services, and proven gmp manufacturing operated by an experienced cmc team. the company also actively seeks creative partnerships to facilitate access to the platform.